These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 7920665)
1. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665 [TBL] [Abstract][Full Text] [Related]
2. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554 [TBL] [Abstract][Full Text] [Related]
4. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220 [TBL] [Abstract][Full Text] [Related]
5. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511 [TBL] [Abstract][Full Text] [Related]
6. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Reeve AE Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076 [TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Vu TH; Chuyen NV; Li T; Hoffman AR Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Moulton T; Crenshaw T; Hao Y; Moosikasuwan J; Lin N; Dembitzer F; Hensle T; Weiss L; McMorrow L; Loew T; Kraus W; Gerald W; Tycko B Nat Genet; 1994 Jul; 7(3):440-7. PubMed ID: 7920666 [TBL] [Abstract][Full Text] [Related]
10. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018 [TBL] [Abstract][Full Text] [Related]
11. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644 [TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting in hepatoblastoma. Rainier S; Dobry CJ; Feinberg AP Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748 [TBL] [Abstract][Full Text] [Related]
13. Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Guo L; Choufani S; Ferreira J; Smith A; Chitayat D; Shuman C; Uxa R; Keating S; Kingdom J; Weksberg R Dev Biol; 2008 Aug; 320(1):79-91. PubMed ID: 18550048 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773 [TBL] [Abstract][Full Text] [Related]
15. Altered expression of imprinted genes in Wilms tumors. Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059 [TBL] [Abstract][Full Text] [Related]
16. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development. Brown KW; Power F; Moore B; Charles AK; Malik KT Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976 [TBL] [Abstract][Full Text] [Related]
17. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642 [TBL] [Abstract][Full Text] [Related]
18. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour. Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739 [TBL] [Abstract][Full Text] [Related]
19. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity. Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576 [TBL] [Abstract][Full Text] [Related]
20. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]